Andreea M. Bujor, MD, PhD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Rheumatology

MD, Iuliu Hațieganu University of Medicine and Pharmacy
PhD, Iuliu Hațieganu University of Medicine and Pharmacy
MS, Iuliu Hațieganu University of Medicine and Pharmacy



Associate Program Director
Boston University
Arthritis & Autoimmune Diseases Research Center
Rheumatology Fellowship Program

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research




The role of FLI1 in myeloid cells and its contribution to cardiac fibrosis
09/15/2021 - 06/30/2026 (PI)
NIH/National Heart, Lung, and Blood Institute
5R01HL155955-02

Spatial frequency domain imaging as a new method to quantify skin changes in scleroderma
04/01/2023 - 03/31/2025 (PI)
Scleroderma Foundation


Spacial frequency domain imaging as a new method to quantify skin changes in Scleroderma
07/01/2022 - 06/30/2023 (PI)
Scleroderma Clinical Trials Consortium


The role of myeloid Fli1 in organ fibrosis in systemic sclerosis
07/01/2020 - 12/31/2021 (PI)
Rheumatology Research Foundation




Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. El-Adili F, Lui JK, Najem M, Farina G, Trojanowska M, Sam F, Bujor AM. Correction: Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications. Arthritis Res Ther. 2023 Jan 23; 25(1):11.View Related Profiles. PMID: 36691037; PMCID: PMC9869504; DOI: 10.1186/s13075-023-02993-0;
     
  2. Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2023 Jan 20.View Related Profiles. PMID: 36662449
     
  3. Raslan AA, Pham TX, Lee J, Hong J, Schmottlach J, Nicolas K, Dinc T, Bujor AM, Caporarello N, Thiriot A, von Andrian UH, Huang SK, Nicosia RF, Trojanowska M, Varelas X, Ligresti G. Single Cell Transcriptomics of Fibrotic Lungs Unveils Aging-associated Alterations in Endothelial and Epithelial Cell Regeneration. bioRxiv. 2023 Jan 20.View Related Profiles. PMID: 36712020; PMCID: PMC9882122; DOI: 10.1101/2023.01.17.523179;
     
  4. Browning JL, Bhawan J, Tseng A, Crossland N, Bujor AM, Akassoglou K, Assassi S, Skaug B, Ho J. Extensive and Persistent Extravascular Dermal Fibrin Deposition Characterizes Systemic Sclerosis. bioRxiv. 2023 Jan 19.View Related Profiles. PMID: 36711912; PMCID: PMC9882194; DOI: 10.1101/2023.01.16.523256;
     
  5. Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2023 Jan 06.View Related Profiles. PMID: 36607535; DOI: 10.1007/s10557-022-07420-1;
     
  6. Sanges S, Rice L, Tu L, Valenzi E, Cracowski JL, Montani D, Mantero JC, Ternynck C, Marot G, Bujor AM, Hachulla E, Launay D, Humbert M, Guignabert C, Lafyatis R. Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis. Ann Rheum Dis. 2023 Mar; 82(3):365-373.View Related Profiles. PMID: 36600187; PMCID: PMC9918672; DOI: 10.1136/ard-2022-223237;
     
  7. El-Adili F, Lui JK, Najem M, Farina G, Trojanowska M, Sam F, Bujor AM. Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications. Arthritis Res Ther. 2022 Nov 11; 24(1):251.View Related Profiles. PMID: 36369212; PMCID: PMC9650849; DOI: 10.1186/s13075-022-02943-2;
     
  8. Sangani RA, Lui JK, Gillmeyer KR, Trojanowski MA, Bujor AM, LaValley MP, Klings ES. Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity. Pulm Circ. 2022 Oct; 12(4):e12117.View Related Profiles. PMID: 36238967; PMCID: PMC9535436; DOI: 10.1002/pul2.12117;
     
  9. Alotaibi M, Shao J, Pauciulo MW, Nichols WC, Hemnes AR, Malhotra A, Kim NH, Yuan JX, Fernandes T, Kerr KM, Alshawabkeh L, Desai AA, Bujor AM, Lafyatis R, Watrous JD, Long T, Cheng S, Chan SY, Jain M. Metabolomic Profiles Differentiate Scleroderma-PAH From Idiopathic PAH and Correspond With Worsened Functional Capacity. Chest. 2023 Jan; 163(1):204-215.View Related Profiles. PMID: 36087794; PMCID: PMC9899641; DOI: 10.1016/j.chest.2022.08.2230;
     
  10. Lui JK, Gillmeyer KR, Sangani RA, Smyth RJ, Gopal DM, Trojanowski MA, Bujor AM, Soylemez Wiener R, LaValley MP, Klings ES. A Multimodal Prediction Model for Diagnosing Pulmonary Hypertension in Systemic Sclerosis. Arthritis Care Res (Hoboken). 2022 Jun 09.View Related Profiles. PMID: 35678779; PMCID: PMC9732142; DOI: 10.1002/acr.24969;
     
Showing 10 of 35 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 35 publications over 10 distinct years, with a maximum of 6 publications in 2010 and 2022

YearPublications
20081
20106
20114
20125
20132
20192
20203
20211
20226
20235

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

scleroderma
Fibrosis
Fibroblasts
Gout
Immunity
Systemic Sclerosis
Contact for Mentoring:

75 E. Newton St Evans Building
Boston MA 02118
Google Map

617.638.4312
Download vCard

Bujor's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (162) concept(s)
_
Co-Authors
See all (27) people
_
Similar People
See all (60) people
_
Same Department
Search Department